That lawsuit argues that patents on human genes violate the First Amendment and U.S. patent law because genes are "products of nature" and therefore can't be patented, according to the American Civil Liberties Union (ACLU).
The Australian Federal Court defeat was a crushing blow for cancer campaigners who have been fighting to have the patent declared invalid since the case was first filed in June 2010.
Supreme court to hear case in U.S.
The lawsuit, filed by the ACLU and the Public Patent Foundation, argues that the patents on genes BRCA1 and BRCA2 are unconstitutional and invalid.
She said Cancer Voices Australia would be pushing for an amendment to Australian law to cover human genes.
That's what we will be advocating for and supporting," she said.